Literature DB >> 10990309

Does the iliolumbar ligament prevent anterior displacement of the fifth lumbar vertebra with defects of the pars?

T Aihara1, K Takahashi, M Yamagata, H Moriya, Y Shimada.   

Abstract

We studied 23 patients with spondylolysis of the fifth lumbar vertebra (L5) and 20 with spondylolytic spondylolisthesis at this level. All were more than 40 years of age. The transverse processes at L5 were significantly wider in the former group than in the latter. We also dissected 56 cadavers to study the morphological relationship between the transverse process of L5 and the iliolumbar ligament, and found that the wider transverse process is associated with increased width of the posterior band of the iliolumbar ligament. If a patient with pars defects has wide transverse processes at L5, the lumbosacral junction may be stabilised by wide posterior bands of the iliolumbar ligament and the fifth lumbar vertebra by the ligament, preventing anterior displacement.

Entities:  

Mesh:

Year:  2000        PMID: 10990309     DOI: 10.1302/0301-620x.82b6.10302

Source DB:  PubMed          Journal:  J Bone Joint Surg Br        ISSN: 0301-620X


  3 in total

1.  Bilateral Pars Defects at the L4 Vertebra Result in Increased Degeneration When Compared With Those at L5: An Anatomic Study.

Authors:  Peter T McCunniff; HoJun Yoo; Anthony Dugarte; Navkirat S Bajwa; Jason O Toy; Uri M Ahn; Nicholas U Ahn
Journal:  Clin Orthop Relat Res       Date:  2015-09-24       Impact factor: 4.176

2.  Mild (not severe) disc degeneration is implicated in the progression of bilateral L5 spondylolysis to spondylolisthesis.

Authors:  Vivek A S Ramakrishna; Uphar Chamoli; Luke L Viglione; Naomi Tsafnat; Ashish D Diwan
Journal:  BMC Musculoskelet Disord       Date:  2018-04-02       Impact factor: 2.362

3.  A finite element analysis of sacroiliac joint displacements and ligament strains in response to three manipulations.

Authors:  Zhun Xu; Yikai Li; Shaoqun Zhang; Liqing Liao; Kai Wu; Ziyu Feng; Dan Li
Journal:  BMC Musculoskelet Disord       Date:  2020-10-28       Impact factor: 2.362

  3 in total

北京卡尤迪生物科技股份有限公司 © 2022-2023.